pentamethylmelamine has been researched along with Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harrap, KR; Muindi, JR; Newell, DR; Smith, IE | 1 |
| Boyd, MR; Dutcher, JS; Jones, RB | 1 |
| Goldberg, RS; Griffin, JP; Krakoff, IH; McSherry, JW | 1 |
| Aisner, J; Chiuten, DF; Lichtenfeld, JL; Van Echo, DA; Whitacre, M; Wiernik, PH | 1 |
| Benjamin, RS; Benvenuto, JA; Loo, TL; Smith, RG; Stewart, DJ | 1 |
| Ajani, JA; Bodey, GP; Cabanillas, FF | 1 |
| Ames, MM; Eagan, RT; Kovach, JS; Powis, G | 1 |
| Clagett-Carr, K; Foster, BJ; Hoth, D; Leyland-Jones, B | 1 |
1 review(s) available for pentamethylmelamine and Neoplasms
| Article | Year |
|---|---|
Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.
Topics: Altretamine; Animals; Antineoplastic Agents; Clinical Trials as Topic; Dogs; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Haplorhini; Humans; Kinetics; Mice; Neoplasms; Structure-Activity Relationship; Triazines | 1986 |
2 trial(s) available for pentamethylmelamine and Neoplasms
| Article | Year |
|---|---|
Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Female; Humans; Kinetics; Liver; Liver Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Nervous System Diseases; Triazines; Vomiting | 1983 |
Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.
Topics: Altretamine; Animals; Antineoplastic Agents; Clinical Trials as Topic; Dogs; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Haplorhini; Humans; Kinetics; Mice; Neoplasms; Structure-Activity Relationship; Triazines | 1986 |
6 other study(ies) available for pentamethylmelamine and Neoplasms
| Article | Year |
|---|---|
A sensitive and specific assay for pentamethylmelamine in plasma: applicability to clinical studies.
Topics: Aged; Altretamine; Antineoplastic Agents; Female; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Male; Middle Aged; Neoplasms; Reference Standards; Triazines | 1980 |
Phase I study of pentamethylmelamine.
Topics: Adult; Altretamine; Dose-Response Relationship, Drug; Drug Evaluation; Electroencephalography; Humans; Injections, Intravenous; Leukocyte Count; Myeloproliferative Disorders; Nausea; Neoplasms; Platelet Count; Psychoses, Substance-Induced; Triazines; Vomiting | 1980 |
Phase I trial of pentamethylmelamine in patients with previously treated malignancies.
Topics: Adult; Aged; Altretamine; Anorexia; Central Nervous System; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Triazines; Vomiting | 1980 |
High-performance liquid chromatographic analysis of pentamethylmelamine and its metabolites in biological fluids.
Topics: Altretamine; Antineoplastic Agents; Chromatography, High Pressure Liquid; Humans; Kinetics; Metabolic Clearance Rate; Neoplasms; Structure-Activity Relationship; Triazines | 1981 |
Phase I trial of pentamethylmelamine.
Topics: Altretamine; Antineoplastic Agents; Bone Marrow; Central Nervous System; Drug Evaluation; Humans; Neoplasms; Triazines | 1982 |
Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans.
Topics: Altretamine; Animals; Biological Availability; Drug Evaluation; Humans; Intestinal Absorption; Liver; Male; Neoplasms; Rabbits; Time Factors; Triazines | 1979 |